Summary of Discussion: Improving Vaccination for Immunocompromised Populations Part II

This RSA board meeting is a continuation of the last meeting, where public health professionals, researchers, vaccine manufacturers, and policy makers discussed challenges and approaches to move forward on risk stratification of immunocompromising conditions, evidence generation, and equitable access to vaccines. See the full summary for more.